
Anthem Biosciences Q2 FY27 Results: Consolidated Net Profit ₹211 Crore on Total Income of ₹653 Crore
Anthem Biosciences (NSE: ANTHEM) reported consolidated total income of ₹652.93 crore and net profit of ₹211.46 crore for the quarter ended 30 Sep 2026, it said in a filing on 03 Nov 2026. Standalone total income was ₹636.80 crore and standalone net profit ₹220.89 crore.
- Earnings
- Contract research and manufacturing (CRDMO) and specialty ingredients